IMV Inc set for best day on progress in coronavirus drug development

Imv

18/03/2020 11:58

** U.S.-listed shares  IMV.O  of Canadian drug developer
surge 85% to $3.77 premarket; Set for biggest one-day gain ever
    ** Company says it is advancing clinical development of a
DPX-based vaccine candidate for coronavirus  urn:newsml:reuters.com:*:nFWN2BB084
    ** DPX is IMV's lipid-based delivery platform
    ** Shares set to open at 3-week high and extend gains for a
second day after 7 days of losses
    ** IMV down 30% YTD

 (Reporting by Susan Mathew in Bengaluru)
 ((Reuters Messaging:
susan.mathew.thomsonreuters.com@reuters.net))